Status:
UNKNOWN
Comparing the Expected Benefit of Extra-corporeal-shockwave Therapy (ESWT) Treatment to Standard Care in Treating Diabetic Foot Ulcers
Lead Sponsor:
Hadassah Medical Organization
Conditions:
Diabetic Foot
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
The purpose of this study is to determine if Extra-corporeal-shockwave Therapy (ESWT) added to standard of care wound therapy significantly improves time to complete wound healing in diabetic foot wou...
Eligibility Criteria
Inclusion
- Signed Informed Consent.
- Diagnosed with Diabetes.
- An Active Diabetic Ulcer larger than 5 cm2
- Sufficient limb perfusion.(e.g no compartment syndrome ankle Brachial Index (ABI)\>=0.5
Exclusion
- Pregnancy.
- The patient is under another research protocol.
- One of the following:
- A. ABI\<0.5 C.Significant Arterial-Venous injury. D. Lymphedema.
- The patient underwent Chemotherapy or Radiotherapy 60 days or less prior to recruitment date.
- Sufficient Noncompliant.
- Sickle Cell Anemia, HIV, Immunodeficiency, HgB Anemia, DVT, Chronic Renal Failure, Systemic use of Steroids
Key Trial Info
Start Date :
January 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2015
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT01499472
Start Date
January 1 2012
End Date
January 1 2015
Last Update
December 26 2011
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.